Indiplon Withdrawn Phase 3 Trials for Insomnia Treatment

IndicationsStatusPurposePhase
WithdrawnTreatment3
clinicaltrials.gov IdentifierTitleDrugs
NCT00525941
An Exploratory Study of NBI-34060 Capsules and Next Day Functioning